Patents by Inventor Neil C. Corley

Neil C. Corley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of detecting a nucleic acid encoding a vesicle transport protein
    Patent number: 5981192
    Abstract: The invention provides a human vesicle transport protein (NVTP-1) and polynucleotides which identify and encode NVTP-1. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NVTP-1.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: November 9, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Neil C. Corley, Preeti Lal
  • Human aflatoxin B1 aldehyde reductase
    Patent number: 5981244
    Abstract: The invention provides a human aflatoxin B1 aldehyde reductase (AFB1-hAR) and polynucleotides which identify and encode AFB1-hAR. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of AFB1-hAR.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: November 9, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Purvi Shah, Karl J. Guegler, Neil C. Corley
  • Human reticulocalbin isoforms
    Patent number: 5976801
    Abstract: The invention provides two human reticulocalbin isoforms designated individually as RCN .gamma. and RCN .delta. and collectively as RCN, and polynucleotides which identify and encode RCN. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of RCN.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: November 2, 1999
    Assignee: Incyte Pharamceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
  • Vesicle transport related protein
    Patent number: 5976865
    Abstract: The invention provides a human vesicle transport related protein (VTRP) and polynucleotides which identify and encode VTRP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of VTRP.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: November 2, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Neil C. Corley, Purvi Shah
  • High affinity immunoglobulin E receptor-like protein
    Patent number: 5977072
    Abstract: The invention provides a human high affinity immunoglobulin E receptor-like protein (IGERB) and polynucleotides which identify and encode IGERB. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of IGERB.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: November 2, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley
  • Human microfibril-associated glycoprotein 4 splice variant
    Patent number: 5972654
    Abstract: The invention provides a human microfibril-associated glycoprotein 4 splice variant (MAG4V) and polynucleotides which identify and encode MAG4V. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of MAG4V.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: October 26, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Y. Tom Tang, Neil C. Corley, Purvi Shah
  • Polynucleotides encoding a protein of embryogenesis
    Patent number: 5972653
    Abstract: The invention provides a human protein of embryogenesis (PREM) and polynucleotides which identify and encode PREM. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PREM.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: October 26, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Ras-like protein
    Patent number: 5973130
    Abstract: The present invention provides a human Ras-like protein (RLP) and polynucleotides which identify and encode RLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing RLP and for treating or preventing disorders associated with expression of RLP.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: October 26, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Surya K. Goli, Neil C. Corley
  • Carbonic anhydrase VIII
    Patent number: 5972684
    Abstract: The invention provides a human carbonic anhydrase isoform (CAVIII) and polynucleotides which identify and encode CAVIII. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of CAVIII.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: October 26, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Henry Yue, Sara R. Greenwald, Neil C. Corley
  • Ubiquitin-like conjugating protein
    Patent number: 5968747
    Abstract: The invention provides a human ubiquitin-like conjugating protein (UBCLE) and polynucleotides which identify and encode UBCLE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of UBCLE.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: October 19, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Human glutaredoxin .beta.
    Patent number: 5968798
    Abstract: The invention provides a human glutaredoxin .beta. (GRX.beta.) and polynucleotides which identify and encode GRX.beta.. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of GRX.beta..
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: October 19, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Human GPI2 homolog
    Patent number: 5968742
    Abstract: The present invention provides a new human GPI2 homolog (GPI-2h) and polynucleotides which identify and encode GPI-2h. The invention also provides expression vectors, host cells, antibodies, and antagonists. The invention also provides methods for the prevention and treatment of diseases associated with expression of GPI-2h, as well as diagnostic assays.
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: October 19, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Neil C. Corley, Purvi Shah
  • Human cornichon molecule
    Patent number: 5968744
    Abstract: The invention provides a human cornichon protein (CORN) and polynucleotides which identify and encode CORN. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of CORN.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: October 19, 1999
    Assignee: Incyte Pharmaceticals, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Maternally transcribed protein
    Patent number: 5965395
    Abstract: The invention provides a human maternally transcribed protein (HMTP) and polynucleotides which identify and encode HMTP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HMTP.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: October 12, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley
  • Human succinyl-coenzyme a synthetase holoenzyme
    Patent number: 5965369
    Abstract: The invention provides human succinyl-CoA synthetase holoenzyme (SCSH) and polynucleotides which identify and encode SCSH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of SCSH.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: October 12, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley, Chandra Patterson
  • Human importin alpha homolog
    Patent number: 5965394
    Abstract: The invention provides a human importin alpha homolog (IMPAH) and polynucleotides which identify and encode IMPAH. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of IMPAH.
    Type: Grant
    Filed: September 18, 1997
    Date of Patent: October 12, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Karl J. Guegler, Neil C. Corley, Purvi Shah
  • Antibody to serine protease precursor
    Patent number: 5965711
    Abstract: The present invention provides a human serine protease precursor (HSPP) and polynucleotides which encode HSPP. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for treating disorders associated with expression of HSPP.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: October 12, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Protein kinase molecules
    Patent number: 5962232
    Abstract: The invention provides human protein kinase molecules (HPKM) and polynucleotides which identify and encode HPKM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HPKM.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: October 5, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Preeti Lal, Ingrid E. Akerblom, Purvi Shah, Neil C. Corley, Karl J. Guegler
  • Human N-acetylneuraminate lyase
    Patent number: 5962302
    Abstract: The invention provides a human N-acetylneuraminate lyase (HNANL) and polynucleotides which identify and encode HNANL. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HNANL.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: October 5, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Human glutathione-S-transferase
    Patent number: 5962231
    Abstract: The invention provides a human glutathione-S-transferase (HGST) and polynucleotides which identify and encode HGST. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HGST.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: October 5, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Henry Yue, Neil C. Corley, Purvi Shah